IL122241A0 - Method for preparing continuous fluorochemical microdispersions - Google Patents

Method for preparing continuous fluorochemical microdispersions

Info

Publication number
IL122241A0
IL122241A0 IL12224196A IL12224196A IL122241A0 IL 122241 A0 IL122241 A0 IL 122241A0 IL 12224196 A IL12224196 A IL 12224196A IL 12224196 A IL12224196 A IL 12224196A IL 122241 A0 IL122241 A0 IL 122241A0
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
pharmaceutical
lipophilic
microdispersion
liquid carrier
Prior art date
Application number
IL12224196A
Other languages
English (en)
Original Assignee
Alliance Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharma filed Critical Alliance Pharma
Publication of IL122241A0 publication Critical patent/IL122241A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
IL12224196A 1995-06-07 1996-06-05 Method for preparing continuous fluorochemical microdispersions IL122241A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,176 US5667809A (en) 1995-06-07 1995-06-07 Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
PCT/US1996/009081 WO1996040053A1 (en) 1995-06-07 1996-06-05 Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents

Publications (1)

Publication Number Publication Date
IL122241A0 true IL122241A0 (en) 1998-04-05

Family

ID=23915021

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12224196A IL122241A0 (en) 1995-06-07 1996-06-05 Method for preparing continuous fluorochemical microdispersions

Country Status (18)

Country Link
US (1) US5667809A (ja)
EP (1) EP0831770B1 (ja)
JP (1) JPH11506783A (ja)
KR (1) KR100454377B1 (ja)
CN (1) CN1192135A (ja)
AT (1) ATE195415T1 (ja)
AU (1) AU721759B2 (ja)
CA (1) CA2222081A1 (ja)
DE (1) DE69609834T2 (ja)
DK (1) DK0831770T3 (ja)
ES (1) ES2150674T3 (ja)
GR (1) GR3034657T3 (ja)
HU (1) HUP9900872A2 (ja)
IL (1) IL122241A0 (ja)
NO (1) NO975320L (ja)
PL (1) PL323829A1 (ja)
PT (1) PT831770E (ja)
WO (1) WO1996040053A1 (ja)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3211740B2 (ja) * 1997-08-28 2001-09-25 ダイキン工業株式会社 化粧料
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
PT1178952E (pt) 1999-05-14 2007-12-04 Univ California Novos moduladores da interleucina-1 e do factor alfa de necrose tumoral, síntese dos referidos moduladores e métodos de utilização dos referidos moduladores
AU2001238212A1 (en) * 2000-02-23 2001-09-03 Aurora Biosciences Corporation Modified fluorescent proteins
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
CA2429163C (en) * 2000-11-16 2013-02-12 The Regents Of The University Of California Marine actinomycete taxon for drug fermentation and product discovery
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7176232B2 (en) * 2002-06-24 2007-02-13 The Regents Of The University Of California Salinosporamides and methods for use thereof
US7112581B2 (en) * 2002-09-27 2006-09-26 Nereus Pharmaceuticals, Inc. Macrocyclic lactams
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
ZA200600473B (en) * 2003-06-20 2007-04-25 Univ California Salinosporamides and methods for use thereof
KR20060026052A (ko) * 2003-06-20 2006-03-22 니리어스 파마슈티컬즈, 인코퍼레이션 암, 염증 및 감염성 질환의 치료를 위한 [3.2.0]헤테로사이클릭 화합물 및 그 유사체의 사용방법
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
BRPI0506535A (pt) * 2004-01-23 2007-02-27 Nereus Pharmaceuticals Inc pirroles bis-indole úteis como agentes anti-microbiais
NZ550910A (en) * 2004-04-30 2011-06-30 Nereus Pharmaceuticals Inc [3.2.0] Heterocyclic compounds and methods of using the same
US7579371B2 (en) 2004-04-30 2009-08-25 Nereus Pharmaceuticals, Inc. Methods of using [3.2.0] heterocyclic compounds and analogs thereof
CA2588923C (en) * 2004-12-03 2015-02-03 Kenneth C. Anderson Compositions and methods for treating neoplastic diseases
DE102005009194B4 (de) * 2005-03-01 2006-12-14 Hpp-Hommel Pharmaceuticals Production Gmbh Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid
US7893299B2 (en) 2005-07-21 2011-02-22 Nereus Pharmaceuticals, Inc. Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators
US7319570B2 (en) 2005-09-19 2008-01-15 Seagate Technology Llc Random vibration and shock compensator using a disturbance observer
US7824698B2 (en) * 2007-02-02 2010-11-02 Nereus Pharmaceuticals, Inc. Lyophilized formulations of Salinosporamide A
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20090017167A1 (en) * 2007-07-11 2009-01-15 Herbalife International Inc. Mixture and beverage made therefrom for protecting cellular hydration
US8394816B2 (en) * 2007-12-07 2013-03-12 Irene Ghobrial Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
EP2276765A4 (en) * 2008-05-12 2011-10-19 Nereus Pharmaceuticals Inc SALINOSPORAMIDE DERIVATIVES AS PROTEASOMAL HEMMER
EP2123256A1 (en) 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
CA2788060C (en) 2010-03-17 2017-07-11 Novaliq Gmbh Pharmaceutical composition for treatment of increased intraocular pressure
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
AU2012260788B2 (en) 2011-05-25 2017-01-19 Dermaliq Therapeutics, Inc. Pharmaceutical composition for administration to nails
EP3192501B1 (en) * 2011-05-25 2020-05-13 Novaliq GmbH Topical pharmaceutical composition based on semifluorinated alkanes
JP5902405B2 (ja) 2011-06-15 2016-04-13 日本オーチス・エレベータ株式会社 エレベータ装置
PT2806886T (pt) 2012-01-23 2017-03-24 Novaliq Gmbh Composições de proteínas estabilizadas baseadas em alcanos semifluorados
EP4342537A3 (en) 2012-09-12 2024-07-03 Novaliq GmbH Semifluorinated alkane compositions
EP3100722B1 (en) 2012-09-12 2024-03-20 Novaliq GmbH Semifluorinated alkanes for use in solubilizing meibum
DK3024484T3 (en) 2013-07-23 2018-10-08 Novaliq Gmbh STABILIZED ANTIBODY COMPOSITIONS
CN106794986A (zh) 2014-09-02 2017-05-31 布平德尔·辛格 氘化或非氘化分子以及药物制剂
EP3204120B1 (en) 2014-10-08 2021-05-26 Pacific Northwest Research Institute Methods and compositions for increasing the potency of antifungal agents
AU2016329261B2 (en) 2015-09-30 2020-05-07 Novaliq Gmbh Semifluorinated compounds for ophthalmic administration
DK3495023T3 (da) 2015-09-30 2020-07-20 Novaliq Gmbh Semifluorerede forbindelser og sammensætninger deraf
US10507132B2 (en) 2016-06-23 2019-12-17 Novaliq Gmbh Topical administration method
MX2019003363A (es) 2016-09-22 2019-10-02 Novaliq Gmbh Composiciones farmaceuticas para usarse en la terapia de la blefaritis.
CN109906085B (zh) 2016-09-23 2024-03-08 诺瓦利克有限责任公司 含有环孢素的眼用组合物
CN110678207B (zh) 2017-04-21 2024-08-02 德马利克治疗公司 碘组合物
WO2018206656A1 (en) 2017-05-12 2018-11-15 Novaliq Gmbh Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
EP3687496A1 (en) 2017-09-27 2020-08-05 Novaliq GmbH Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
CA3076567A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh Ophthalmic compositions
SG11202007858VA (en) 2018-03-02 2020-09-29 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
WO2019191119A1 (en) 2018-03-28 2019-10-03 Herbalife International Of America, Inc. Acetylation of polysaccharides
CA3111870C (en) 2018-09-27 2022-04-12 Novaliq Gmbh Topical sunscreen formulation
BR112021005350A8 (pt) 2018-09-27 2023-03-21 Novaliq Gmbh Reparo de barreira lipídica
CN112823020A (zh) 2018-10-12 2021-05-18 诺瓦利克有限责任公司 用于治疗干眼病的眼用组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975512A (en) * 1970-12-21 1976-08-17 University Of Illinois Foundation Non-toxic brominated perfluorocarbons radiopaque agents
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
FR2602774B1 (fr) * 1986-07-29 1990-10-19 Atta Nouvelles molecules amphiphiles polyhydroxylees et perfluoroalkylees ayant des proprietes tensioactives
FR2620445B1 (fr) * 1987-09-16 1990-07-20 Centre Nat Rech Scient Nouveaux derives fluores d'acides amines, utilisables en particulier comme agents tensioactifs ou cotensioactifs et preparations a usage biomedical comprenant ces derives
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
DK0478686T3 (da) * 1989-06-22 1993-11-29 Alliance Pharma Flour- og phosphorholdige amphiphile molekyler med overfladeaktive egenskaber
FR2665705B1 (fr) * 1990-08-09 1993-07-30 Atta Nouveaux derives fluores amphiphiles a structure telomere, leur procede de preparation et leur utilisation dans des preparations a usage biomedical.
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US5292499A (en) * 1990-09-11 1994-03-08 University Of Wales College Of Cardiff Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5496535A (en) * 1991-04-12 1996-03-05 Alliance Pharmaceutical Corp. Fluorocarbon contrast media for use with MRI and radiographic imaging
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
CA2151491A1 (en) * 1992-12-24 1994-07-07 Robert J. Kaufman Fluorocarbon emulsions
FR2700696B1 (fr) * 1993-01-28 1995-04-07 Atta Dispersions, émulsions, microémulsions, gels et compositions à usage biomédical comprenant un composé organique fluoré iodé, utilisables notamment comme agent de contraste.
FR2720943B1 (fr) * 1994-06-09 1996-08-23 Applic Transferts Technolo Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.

Also Published As

Publication number Publication date
CN1192135A (zh) 1998-09-02
ES2150674T3 (es) 2000-12-01
WO1996040053A1 (en) 1996-12-19
KR100454377B1 (ko) 2005-08-04
EP0831770B1 (en) 2000-08-16
KR19990022587A (ko) 1999-03-25
JPH11506783A (ja) 1999-06-15
NO975320D0 (no) 1997-11-19
DE69609834D1 (de) 2000-09-21
DE69609834T2 (de) 2000-12-21
MX9709690A (es) 1998-03-29
PL323829A1 (en) 1998-04-27
EP0831770A1 (en) 1998-04-01
HUP9900872A2 (hu) 1999-08-30
PT831770E (pt) 2000-11-30
CA2222081A1 (en) 1996-12-19
AU721759B2 (en) 2000-07-13
AU6049496A (en) 1996-12-30
DK0831770T3 (da) 2000-12-18
ATE195415T1 (de) 2000-09-15
GR3034657T3 (en) 2001-01-31
US5667809A (en) 1997-09-16
NO975320L (no) 1998-01-27

Similar Documents

Publication Publication Date Title
IL122241A0 (en) Method for preparing continuous fluorochemical microdispersions
CA2411153A1 (en) Method for preparing a composition
CA2102494A1 (en) A pharmaceutical composition containing a defined lipid system
AU623004B2 (en) Solid imaging method utilizing photohardenable compositions of self limiting thickness by phase separation
HUT61751A (en) Process for producing benzofuran derivatives and pharmaceutical compositions comprising such compounds as active ingredient
NO901189D0 (no) Fremgangsmaate for elektrolytisk fremstilling av rent magnesium.
GB0125604D0 (en) Novel process
CA2176360A1 (en) Pharmaceutical emulsion
AU2975195A (en) Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
HUP0300836A2 (hu) Taxánokat tartalmazó szájon át beadható gyógyszerkészítmények és ezek alkalmazása
RU94007635A (ru) Комбинированный препарат для контрацепции
CA2294033A1 (en) Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
CA2099771A1 (en) Liposomal-polyene preliposomal powder and method for its preparation
GR1002295B (el) Στερεες φαρμακευτικες συνθεσεις και μεθοδος για την παρασκευη τους.
KR960000247A (ko) 사이클로스포린a 함유 조성물 및 그의 제조방법
BG103060A (en) 19-nor-holan steroids as neurochemical initiators of the change of the operation of the hypothalamus in human organism
WO2000054763A3 (en) Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
SE9302295D0 (sv) New pharmaceutical composition
CA2162919A1 (en) Rectal Compositions
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
Hotta Tsuchiya, K.: Kartini's Image of Java's Landscape
JPS5265261A (en) Synthesis of 1alpha-hyaroxy-provitamine d compounds
RU97120225A (ru) Фармацевтическая композиция, содержащая гидрохлорид тиагабина, и способ ее получения
JPS52102287A (en) Preparation of cyclic lactones
MX9602270A (es) Composicion farmaceutica aplicable oralmente.